Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 6.15% | 54.02 | 0.9% | $2353.35m | |
| JNJ | Johnson & Johnson | -0.62% | 159.25 | 0.7% | $1167.23m | |
| MRK | Merck & Co., Inc. | -3.83% | 79.13 | 0.7% | $1134.44m | |
| LLY | Eli Lilly & Co. | -0.57% | 260.50 | 1.1% | $694.38m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 56.51 | 1.0% | $694.21m | |
| ABBV | AbbVie, Inc. | -1.80% | 116.53 | 1.9% | $669.66m | |
| AZN | AstraZeneca Plc | 0.43% | 56.58 | 1.0% | $278.35m | |
| GSK | GlaxoSmithKline Plc | -1.42% | 41.01 | 0.2% | $185.81m | |
| NVS | Novartis AG | -1.44% | 80.73 | 0.2% | $180.89m | |
| BFRI | Biofrontera, Inc. | 51.34% | 7.90 | 0.0% | $139.46m | |
| VTRS | Viatris, Inc. | -2.30% | 12.75 | 0.0% | $132.99m | |
| RGEN | Repligen Corp. | 5.21% | 286.01 | 6.7% | $112.80m | |
| RPRX | Royalty Pharma Plc | -0.45% | 41.89 | 0.1% | $106.76m | |
| DRNA | Dicerna Pharmaceuticals, Inc. | -0.03% | 37.99 | 0.3% | $106.72m | |
| NVO | Novo Nordisk A/S | -0.76% | 108.21 | 0.1% | $96.98m |
Company Profile
Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA.